UNSPSC 85523426: Occlusion of left basilic vein with intraluminal device, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to occlusion of left basilic vein with intraluminal device, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05LC0DZ

UNSPSC 85523426 Occlusion of left basilic vein with intraluminal device, open approach is a Commodity code that shows minimal alignment with actual state and local government procurement activity. Recent opportunities tagged with this code do not involve medical device placement or surgical procedure materials; instead, they reflect health plan administration, occupational medical surveillance, temporary clinical staffing, and pharmacy benefit management services—none of which correspond to the procedural intervention the code nominally describes. The issuing bodies span county health systems, municipal retirement offices, state transportation departments, county probation authorities, and county benefit consortia, reflecting a fragmented buyer landscape across health administration and occupational health functions rather than procurement of surgical devices or interventional supplies.

The code shows no recent opportunities with actual relevance to basilic vein occlusion devices or related interventional materials. The City of Phoenix Retirement Office sought independent medical evaluation services for disability determinations (RFP RTMRFP26001, due October 16, 2026); the Washington State Department of Transportation requested occupational medical surveillance services across 14 ferry system locations (RFP RFP20260825, due October 9, 2026); the County of Santa Clara Health System established a qualified vendor pool for temporary ancillary clinical staffing (RFSQHHSFY270052, due October 7, 2026); and Collier County sought pharmacy benefit management services covering approximately $8.7 million in annual pharmacy spending (RFP 25-8414). The recent opportunities cluster in California, Arizona, Washington, and Florida. This code does not appear to reflect a live procurement market for the device or procedure category it nominally names; business development teams should verify correct UNSPSC classification or consider this a mistagged category unlikely to generate relevant RFP, RFQ, or ITB activity.